Jennifer L Driver, MD
Family Practice · Metairie
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Crescent City Physicians Inc · 158 clinicians in this group
Hospitals listed: Touro Infirmary · West Jefferson Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Driver’s office at (504) 325-2929 to ask if they take your plan before you enroll.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 96.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Touro InfirmaryNew Orleans, LAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of LCMC Health System, which runs 11 hospitalsPatients rate it 4 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.127, Oct 2024 – Sep 2025
- West Jefferson Medical CenterMarrero, LAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of LCMC Health System, which runs 11 hospitalsPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.263, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.15, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Touro Infirmary
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.127 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.03) · 384 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1 (0.6 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.5 · 123 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.5 · 107 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.3 · 148 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.2 · 1,618 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 2,016 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,099 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.84 (0.46 to 5.22) · 585 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0 to 3.24) · 236 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.87 (0.32 to 3.43) · 559 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.64 (1.55 to 17.72) · 222 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.28 (2.2 to 10.36) · 243 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.08 (0.56 to 3.6) · 107 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.65 (0 to 1.58) · 1,783 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.208 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.587 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.011 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.77 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.817 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 175 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 385 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -22.9 · 61 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 45.2 · 137 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 58.9 · 111 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.8 · 216 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.7 (4.6 to 9.5) · 172 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10 (7.1 to 13.7) · 172 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11.6 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.1 · 123 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.2 to 16.8) · 352 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 326 cases | No different | Jan 2024 – Dec 2024 |
What patients said (985 patients answered, 21% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 64% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for West Jefferson Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 6 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.263 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.15 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0 to 2) · 407 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.95 (0.56 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 10.8 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 16.2 · 162 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 90 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.9 · 288 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 2,296 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 2,382 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,396 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.8 (0.43 to 5.16) · 559 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.34) · 236 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.24 (0.65 to 3.83) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.71 (4.19 to 21.24) · 248 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.43 (1.36 to 9.5) · 229 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.2 to 3.22) · 125 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.15) · 1,998 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 35 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 135 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23.1 · 576 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.4 · 188 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.8 · 92 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 251 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.6) · 89 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.9 (7 to 14) · 89 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 7.8 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 269 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.2 to 16.9) · 130 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 170 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,121 patients answered, 21% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 66% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$19,684
Medicare paid this office $19,684 for 110 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 59 | $7,705 | $131 |
| Return visit (30+ min) | 44 | $5,371 | $83 |
| Short return visit (20+ min) | 26 | $1,650 | $53 |
Who their Medicare patients are
110 Original Medicare patients in 2024. Average age 70 · Women 70% · Also on Medicaid 12% · Health risk score 0.80. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 61% · Cancer 24% · Coronary heart disease 17% · Diabetes 16% · Depression 15% · Heart failure 10%.
The office billed $55,527, Medicare allowed $23,538 and paid $19,684; for 409 services of 23 kinds; $1,755 of it was for drugs given in the office and $17,930 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 110 | 409 | 70 | 0.80 | $55,527 | $19,684 |
| 2023 | 97 | 187 | 72 | 0.84 | $47,171 | $17,985 |
| 2022 | 103 | 296 | 71 | 0.99 | $58,581 | $20,748 |
| 2021 | 87 | 331 | 71 | 1.00 | $59,666 | $19,956 |
| 2020 | 71 | 185 | 69 | 1.06 | $41,110 | $13,138 |
| 2019 | 44 | 98 | 66 | 1.34 | $21,161 | $6,977 |
| 2018 | 27 | 42 | 66 | 1.54 | $5,472 | $2,592 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 58 | $7,405 | $128 |
| Return visit (30+ min) | 32 | $3,058 | $83 |
| Short return visit (20+ min) | 25 | $1,784 | $59 |
| Administration of influenza virus vaccine | 11 | $330 | $30 |
2022: 7 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 49 | $6,395 | $131 |
| Return visit (30+ min) | 52 | $5,253 | $78 |
| Short return visit (20+ min) | 25 | $1,734 | $64 |
| New patient visit (45+ min) | 13 | $1,092 | $84 |
| Influenza vaccine split virus, preservative free | 11 | $747 | $68 |
| Administration of pneumococcal vaccine | 14 | $402 | $29 |
| Administration of influenza virus vaccine | 11 | $315 | $29 |
2021: 6 services
| Return visit (30+ min) | 45 | $5,306 | $86 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 37 | $4,937 | $133 |
| New patient visit (45+ min) | 22 | $2,835 | $129 |
| Influenza vaccine split virus, preservative free | 11 | $718 | $65 |
| Administration of pneumococcal vaccine | 15 | $248 | $17 |
| Administration of influenza virus vaccine | 11 | $181 | $16 |
2020: 7 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 23 | $2,692 | $117 |
| Return visit (30+ min) | 17 | $1,466 | $73 |
| New patient visit (30+ min) | 21 | $1,348 | $64 |
| Short return visit (20+ min) | 22 | $1,289 | $43 |
| Influenza vaccine split virus, preservative free | 13 | $793 | $61 |
| Administration of influenza virus vaccine | 14 | $233 | $17 |
| Administration of pneumococcal vaccine | 13 | $217 | $17 |
2019: 3 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 16 | $1,837 | $115 |
| Short return visit (20+ min) | 13 | $1,113 | $56 |
| Return visit (30+ min) | 12 | $1,030 | $86 |
2018: 1 service
| New patient visit (30+ min) | 11 | $492 | $45 |
Medicaid work
$13,825 in 2024
Medicaid paid $13,825 for 2,737 billed services this clinician did in 2024, up to 48 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 157 | $7,717 |
| Short return visit (20+ min) | 177 | $6,108 |
| Current tobacco non-smoker and not currently exposed to secondhand smoke (Asthma) | 451 | $0 |
| Pain severity quantified; pain present (COA) (ONC) | 47 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 433 | $0 |
| Medication list documented in medical record (COA) | 148 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 148 | $0 |
| FXNL STATUS ASSESSED | 148 | $0 |
| BODY MASS INDEX DOCD | 260 | $0 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 79 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 113 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 58 | $0 |
| 2024 | 2,737 | 17 | 48 | $13,825 |
| 2023 | 1,510 | 16 | 61 | $18,290 |
| 2022 | 493 | 5 | 39 | $20,113 |
| 2021 | 630 | 5 | 43 | $30,381 |
| 2020 | 376 | 2 | 28 | $13,858 |
| 2019 | 388 | 4 | 29 | $14,137 |
| 2018 | 243 | 2 | 21 | $8,039 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 184 | $9,460 |
| Short return visit (20+ min) | 232 | $8,030 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 12 | $800 |
| Current tobacco non-smoker and not currently exposed to secondhand smoke (Asthma) | 15 | $0 |
| Pain severity quantified; pain present (COA) (ONC) | 34 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 113 | $0 |
| Medication list documented in medical record (COA) | 177 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 191 | $0 |
| BODY MASS INDEX DOCD | 139 | $0 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 126 | $0 |
| MOST RECENT LDL-C <100 MG/DL | 15 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 91 | $0 |
2022
| Return visit (30+ min) | 258 | $12,159 |
| Short return visit (20+ min) | 196 | $6,648 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 14 | $800 |
| Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use | 12 | $329 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 13 | $176 |
2021
| Return visit (30+ min) | 378 | $20,315 |
| Short return visit (20+ min) | 184 | $6,796 |
| New patient visit (45+ min) | 30 | $2,317 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 12 | $600 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 26 | $353 |
2020
| Short return visit (20+ min) | 326 | $11,352 |
| Return visit (30+ min) | 50 | $2,506 |
2019
| Short return visit (20+ min) | 322 | $10,722 |
| New patient visit (30+ min) | 40 | $1,868 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; 18-39 years | 12 | $857 |
| Return visit (30+ min) | 14 | $689 |
2018
| Short return visit (20+ min) | 187 | $5,424 |
| New patient visit (30+ min) | 56 | $2,615 |
Drugs they prescribed that Part D paid
$535,596
Pharmacies billed $535,596 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (71 of 5,061) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
4,311 generic and 718 brand-name prescriptions · $535,596 in drug cost · 79 antibiotic prescriptions to 58 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mounjaro | 100 | $138,921 | $1,389 |
| Ozempic | 71 | $74,237 | $1,046 |
| Jardiance | 68 | $73,668 | $1,083 |
| Eliquis | 45 | $38,878 | $864 |
| Prolia | 21 | $36,436 | $1,735 |
See all 99 drugs
| Mounjaro | 100 | $138,921 | $1,389 |
| Ozempic | 71 | $74,237 | $1,046 |
| Jardiance | 68 | $73,668 | $1,083 |
| Eliquis | 45 | $38,878 | $864 |
| Prolia | 21 | $36,436 | $1,735 |
| Nurtec Odt | 11 | $19,569 | $1,779 |
| Wegovy | 13 | $17,951 | $1,381 |
| Synthroid | 52 | $6,008 | $116 |
| Atorvastatin | 335 | $3,352 | $10 |
| Levothyroxine | 287 | $2,319 | $8 |
| Estradiol | 32 | $2,123 | $66 |
| Lantus | 20 | $1,768 | $88 |
| Valsartan | 49 | $1,575 | $32 |
| Losartan | 167 | $1,346 | $8 |
| Gabapentin | 128 | $1,335 | $10 |
| Rosuvastatin | 110 | $1,295 | $12 |
| Omeprazole | 74 | $1,205 | $16 |
| Duloxetine | 37 | $1,157 | $31 |
| Albuterol Sulfate Hfa | 43 | $1,114 | $26 |
| Potassium Chloride | 68 | $1,081 | $16 |
| Metformin | 112 | $942 | $8 |
| Amlodipine Besylate | 220 | $933 | $4 |
| Dextroamphetamine-Amphetamine | 32 | $889 | $28 |
| Bupropion Xl | 36 | $865 | $24 |
| Metoprolol | 76 | $838 | $11 |
| Irbesartan | 39 | $831 | $21 |
| Valacyclovir | 14 | $817 | $58 |
| Lisinopril | 105 | $804 | $8 |
| Pantoprazole | 79 | $764 | $10 |
| Mirtazapine | 28 | $732 | $26 |
| Ezetimibe | 53 | $726 | $14 |
| Azelastine | 31 | $634 | $20 |
| Carvedilol | 40 | $632 | $16 |
| Hydrochlorothiazide | 98 | $629 | $6 |
| Tamsulosin | 56 | $614 | $11 |
| Allopurinol | 44 | $604 | $14 |
| Escitalopram | 81 | $595 | $7 |
| Nifedipine Er | 27 | $587 | $22 |
| Raloxifene | 22 | $558 | $25 |
| Amitriptyline | 39 | $537 | $14 |
| Fenofibrate | 20 | $528 | $26 |
| Pregabalin | 18 | $424 | $24 |
| Sertraline | 41 | $406 | $10 |
| Oxybutynin Chloride Er | 39 | $401 | $10 |
| Trazodone | 77 | $387 | $5 |
| Atenolol | 36 | $387 | $11 |
| Pravastatin | 42 | $382 | $9 |
| Simvastatin | 50 | $335 | $7 |
| Clonazepam | 58 | $333 | $6 |
| Montelukast | 28 | $320 | $11 |
| Olmesartan Medoxomil | 15 | $309 | $21 |
| Famotidine | 24 | $297 | $12 |
| Alendronate | 59 | $276 | $5 |
| Oxycodone | 31 | $264 | $9 |
| Losartan-Hydrochlorothiazide | 35 | $264 | $8 |
| Cefdinir | 13 | $253 | $19 |
| Metformin Hcl Er | 61 | $229 | $4 |
| Paroxetine | 14 | $222 | $16 |
| Clopidogrel | 26 | $221 | $8 |
| Furosemide | 44 | $216 | $5 |
| Fluoxetine | 30 | $210 | $7 |
| Meloxicam | 39 | $199 | $5 |
| Cyclobenzaprine | 17 | $198 | $12 |
| Venlafaxine | 11 | $191 | $17 |
| Tizanidine | 27 | $185 | $7 |
| Spironolactone | 13 | $184 | $14 |
| Venlafaxine Hcl Er | 11 | $182 | $17 |
| Clotrimazole-Betamethasone | 11 | $167 | $15 |
| Finasteride | 12 | $164 | $14 |
| Hydrocodone-Acetaminophen | 18 | $159 | $9 |
| Fluticasone Propionate | 16 | $158 | $10 |
| Citalopram Hbr | 43 | $156 | $4 |
| Olmesartan-Hydrochlorothiazide | 12 | $152 | $13 |
| Fluconazole | 14 | $148 | $11 |
| Alprazolam | 74 | $143 | $2 |
| Chlorthalidone | 11 | $133 | $12 |
| Benazepril | 12 | $130 | $11 |
| Doxycycline Monohydrate | 12 | $127 | $11 |
| Lorazepam | 38 | $117 | $3 |
| Buspirone | 18 | $116 | $6 |
| Metoprolol | 16 | $112 | $7 |
| Levocetirizine Dihydrochloride | 11 | $110 | $10 |
| Enalapril Maleate | 16 | $109 | $7 |
| Triamterene-Hydrochlorothiazid | 12 | $103 | $9 |
| Zolpidem | 45 | $98 | $2 |
| Methylphenidate | 11 | $94 | $9 |
| Methocarbamol | 18 | $91 | $5 |
| Butalbital-Acetaminophen-Caffe | 13 | $90 | $7 |
| Glimepiride | 11 | $88 | $8 |
| Ibuprofen | 14 | $81 | $6 |
| Cephalexin | 13 | $75 | $6 |
| Topiramate | 12 | $72 | $6 |
| Dropsafe Prep Pads | 12 | $67 | $6 |
| Diazepam | 20 | $52 | $3 |
| Tramadol | 18 | $47 | $3 |
| Triamcinolone Acetonide | 12 | $44 | $4 |
| Prednisone | 14 | $43 | $3 |
| Ondansetron | 12 | $40 | $3 |
| Ciprofloxacin | 11 | $33 | $3 |
Year by year
| 2024 | 5,061 | 388 | 1% (71) | 14% | $535,596 |
| 2023 | 4,667 | 372 | 1% (55) | 14% | $545,736 |
| 2022 | 3,914 | 356 | 1% (42) | 11% | $290,482 |
| 2021 | 2,830 | 271 | 1% (38) | 11% | $169,404 |
| 2020 | 1,722 | 192 | 3% (46) | 12% | $135,121 |
| 2019 | 914 | 102 | 4% (36) | 9% | $43,594 |
| 2018 | 265 | 51 | 6% (15) | None | $9,260 |
| 2017 | 574 | 114 | 2% (13) | None | $26,462 |
| 2016 | 777 | 141 | 4% (31) | None | $33,846 |
| 2015 | 381 | 100 | None | None | $21,224 |
| 2014 | 80 | 32 | None | 15% | $2,683 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 98 drugs
| Ozempic | 107 | $130,042 | $1,215 |
| Jardiance | 39 | $53,451 | $1,371 |
| Mounjaro | 45 | $50,919 | $1,132 |
| Prolia | 25 | $42,684 | $1,707 |
| Eliquis | 41 | $41,927 | $1,023 |
| Nurtec Odt | 27 | $41,295 | $1,529 |
| Victoza 3-Pak | 12 | $19,170 | $1,598 |
| Farxiga | 13 | $6,767 | $521 |
| Synthroid | 57 | $6,321 | $111 |
| Myrbetriq | 13 | $6,042 | $465 |
| Breo Ellipta | 14 | $6,014 | $430 |
| Lantus | 12 | $4,968 | $414 |
| Atorvastatin | 326 | $4,044 | $12 |
| Humulin N | 11 | $3,484 | $317 |
| Levothyroxine | 245 | $3,274 | $13 |
| Estradiol | 25 | $1,996 | $80 |
| Losartan | 139 | $1,526 | $11 |
| Metoprolol | 99 | $1,521 | $15 |
| Valsartan | 17 | $1,493 | $88 |
| Gabapentin | 106 | $1,417 | $13 |
| Albuterol Sulfate Hfa | 35 | $1,282 | $37 |
| Valacyclovir | 14 | $1,203 | $86 |
| Irbesartan | 35 | $1,190 | $34 |
| Amlodipine Besylate | 204 | $1,160 | $6 |
| Rosuvastatin | 93 | $1,020 | $11 |
| Pregabalin | 16 | $996 | $62 |
| Lisinopril | 121 | $992 | $8 |
| Omeprazole | 67 | $987 | $15 |
| Potassium Chloride | 57 | $909 | $16 |
| Raloxifene | 16 | $905 | $57 |
| Escitalopram | 77 | $862 | $11 |
| Duloxetine | 32 | $833 | $26 |
| Pravastatin | 57 | $832 | $15 |
| Allopurinol | 55 | $776 | $14 |
| Metformin | 88 | $775 | $9 |
| Carvedilol | 65 | $753 | $12 |
| Tamsulosin | 65 | $727 | $11 |
| Bupropion Xl | 30 | $713 | $24 |
| Pantoprazole | 67 | $712 | $11 |
| Sertraline | 56 | $701 | $13 |
| Ezetimibe | 44 | $671 | $15 |
| Felodipine Er | 11 | $667 | $61 |
| Nifedipine Er | 22 | $663 | $30 |
| Hydrochlorothiazide | 109 | $654 | $6 |
| Losartan-Hydrochlorothiazide | 33 | $650 | $20 |
| Oxybutynin Chloride Er | 33 | $582 | $18 |
| Azelastine | 16 | $575 | $36 |
| Mirtazapine | 28 | $560 | $20 |
| Fluticasone Propionate | 49 | $529 | $11 |
| Amitriptyline | 34 | $499 | $15 |
| Alendronate | 56 | $483 | $9 |
| Diltiazem 24hr Er (Cd) | 15 | $453 | $30 |
| Levoxyl | 14 | $395 | $28 |
| Clonazepam | 66 | $389 | $6 |
| Atenolol | 37 | $379 | $10 |
| Cefdinir | 16 | $346 | $22 |
| Olanzapine | 14 | $337 | $24 |
| Oxycodone-Acetaminophen | 18 | $336 | $19 |
| Trazodone | 67 | $334 | $5 |
| Montelukast | 19 | $302 | $16 |
| Memantine | 15 | $265 | $18 |
| Sotalol | 15 | $263 | $18 |
| Buspirone | 26 | $261 | $10 |
| Methocarbamol | 24 | $253 | $11 |
| Paroxetine | 17 | $247 | $15 |
| Citalopram Hbr | 36 | $235 | $7 |
| Clopidogrel | 20 | $210 | $11 |
| Methylphenidate | 15 | $203 | $14 |
| Venlafaxine | 12 | $202 | $17 |
| Triamterene-Hydrochlorothiazid | 16 | $194 | $12 |
| Fluoxetine | 32 | $191 | $6 |
| Enalapril Maleate | 17 | $190 | $11 |
| Furosemide | 36 | $181 | $5 |
| Triamcinolone Acetonide | 20 | $170 | $8 |
| Alprazolam | 50 | $169 | $3 |
| Cyclobenzaprine | 14 | $169 | $12 |
| Finasteride | 11 | $161 | $15 |
| Zolpidem | 34 | $160 | $5 |
| Simvastatin | 23 | $158 | $7 |
| Baclofen | 13 | $151 | $12 |
| Metformin Hcl Er | 56 | $138 | $2 |
| Metoprolol | 22 | $135 | $6 |
| Chlorthalidone | 12 | $135 | $11 |
| Hydrocodone-Acetaminophen | 11 | $123 | $11 |
| Tizanidine | 21 | $121 | $6 |
| Meloxicam | 44 | $121 | $3 |
| Lisinopril-Hydrochlorothiazide | 16 | $119 | $7 |
| Paxlovid (Eua) | 11 | $118 | $11 |
| Ibuprofen | 29 | $106 | $4 |
| Diazepam | 27 | $95 | $4 |
| Temazepam | 13 | $91 | $7 |
| Lorazepam | 24 | $87 | $4 |
| Glimepiride | 18 | $73 | $4 |
| Methylprednisolone | 11 | $69 | $6 |
| Lovastatin | 18 | $64 | $4 |
| Ondansetron | 13 | $54 | $4 |
| Tramadol | 18 | $38 | $2 |
| Cephalexin | 12 | $33 | $3 |
2022: 81 drugs
| Ozempic | 37 | $41,308 | $1,116 |
| Jardiance | 26 | $40,263 | $1,549 |
| Eliquis | 45 | $33,356 | $741 |
| Prolia | 19 | $29,483 | $1,552 |
| Synthroid | 47 | $5,109 | $109 |
| Myrbetriq | 12 | $4,829 | $402 |
| Duloxetine | 53 | $4,250 | $80 |
| Humulin N | 11 | $3,492 | $317 |
| Atorvastatin | 287 | $3,381 | $12 |
| Levothyroxine | 177 | $2,819 | $16 |
| Rosuvastatin | 101 | $2,472 | $24 |
| Albuterol Sulfate Hfa | 38 | $2,070 | $54 |
| Valsartan | 16 | $1,724 | $108 |
| Gabapentin | 79 | $1,479 | $19 |
| Metoprolol | 74 | $1,408 | $19 |
| Fenofibrate | 13 | $1,372 | $106 |
| Estradiol | 18 | $1,313 | $73 |
| Amlodipine Besylate | 185 | $1,298 | $7 |
| Losartan | 142 | $1,156 | $8 |
| Potassium Chloride | 41 | $1,049 | $26 |
| Ezetimibe | 38 | $947 | $25 |
| Valacyclovir | 18 | $899 | $50 |
| Irbesartan | 25 | $886 | $35 |
| Pravastatin | 41 | $837 | $20 |
| Tamsulosin | 54 | $790 | $15 |
| Bupropion Xl | 39 | $775 | $20 |
| Omeprazole | 48 | $739 | $15 |
| Escitalopram | 72 | $729 | $10 |
| Nifedipine Er | 14 | $697 | $50 |
| Metformin | 89 | $689 | $8 |
| Alendronate | 67 | $687 | $10 |
| Pantoprazole | 76 | $676 | $9 |
| Oxybutynin Chloride Er | 11 | $650 | $59 |
| Montelukast | 36 | $637 | $18 |
| Azelastine | 17 | $625 | $37 |
| Allopurinol | 42 | $582 | $14 |
| Fluticasone Propionate | 44 | $556 | $13 |
| Amitriptyline | 35 | $553 | $16 |
| Lisinopril | 92 | $538 | $6 |
| Sertraline | 68 | $536 | $8 |
| Hydrochlorothiazide | 82 | $517 | $6 |
| Trazodone | 65 | $503 | $8 |
| Carvedilol | 45 | $473 | $11 |
| Sotalol | 16 | $396 | $25 |
| Losartan-Hydrochlorothiazide | 18 | $363 | $20 |
| Bupropion | 13 | $360 | $28 |
| Lisinopril-Hydrochlorothiazide | 19 | $308 | $16 |
| Methocarbamol | 27 | $284 | $11 |
| Paroxetine | 16 | $283 | $18 |
| Doxycycline Monohydrate | 13 | $278 | $21 |
| Atenolol | 33 | $263 | $8 |
| Citalopram Hbr | 25 | $258 | $10 |
| Clopidogrel | 20 | $244 | $12 |
| Meloxicam | 46 | $241 | $5 |
| Hydroxyzine Pamoate | 33 | $211 | $6 |
| Clonazepam | 53 | $211 | $4 |
| Buspirone | 14 | $204 | $15 |
| Meclizine | 16 | $200 | $12 |
| Hydrocodone-Acetaminophen | 16 | $199 | $12 |
| Fluoxetine | 31 | $190 | $6 |
| Cefdinir | 12 | $187 | $16 |
| Alprazolam | 23 | $164 | $7 |
| Olanzapine | 13 | $162 | $12 |
| Zolpidem | 23 | $159 | $7 |
| Metformin Hcl Er | 46 | $154 | $3 |
| Tizanidine | 23 | $153 | $7 |
| Triamterene-Hydrochlorothiazid | 11 | $152 | $14 |
| Furosemide | 28 | $138 | $5 |
| Chlorthalidone | 11 | $135 | $12 |
| Simvastatin | 17 | $133 | $8 |
| Triamcinolone Acetonide | 22 | $132 | $6 |
| Metoprolol | 18 | $128 | $7 |
| Lovastatin | 16 | $118 | $7 |
| Cyclobenzaprine | 13 | $111 | $9 |
| Celecoxib | 11 | $104 | $9 |
| Glipizide | 12 | $86 | $7 |
| Tramadol | 17 | $61 | $4 |
| Glimepiride | 19 | $57 | $3 |
| Ciprofloxacin | 11 | $50 | $5 |
| Fluconazole | 11 | $42 | $4 |
| Diazepam | 12 | $36 | $3 |
2021: 67 drugs
| Jardiance | 11 | $16,879 | $1,534 |
| Eliquis | 22 | $13,317 | $605 |
| Ozempic | 11 | $9,722 | $884 |
| Levemir Flextouch | 12 | $5,500 | $458 |
| Breo Ellipta | 13 | $5,187 | $399 |
| Synthroid | 40 | $3,920 | $98 |
| Crestor | 11 | $3,732 | $339 |
| Humulin N | 11 | $3,492 | $317 |
| Levothyroxine | 138 | $2,205 | $16 |
| Rosuvastatin | 88 | $1,860 | $21 |
| Atorvastatin | 193 | $1,699 | $9 |
| Albuterol Sulfate Hfa | 30 | $1,480 | $49 |
| Metoprolol | 61 | $1,167 | $19 |
| Clorazepate Dipotassium | 12 | $1,166 | $97 |
| Duloxetine | 28 | $1,063 | $38 |
| Gabapentin | 62 | $1,047 | $17 |
| Omeprazole | 65 | $933 | $14 |
| Losartan | 113 | $911 | $8 |
| Amlodipine Besylate | 132 | $805 | $6 |
| Potassium Chloride | 27 | $755 | $28 |
| Ultra-Fine Short Pen Needle | 14 | $742 | $53 |
| Nifedipine Er | 16 | $740 | $46 |
| Azelastine | 19 | $701 | $37 |
| Irbesartan | 15 | $624 | $42 |
| Bupropion Xl | 20 | $498 | $25 |
| Fluticasone Propionate | 33 | $483 | $15 |
| Alendronate | 51 | $480 | $9 |
| Pantoprazole | 53 | $461 | $9 |
| Pregabalin | 14 | $459 | $33 |
| Amitriptyline | 17 | $426 | $25 |
| Ezetimibe | 24 | $425 | $18 |
| Montelukast | 39 | $412 | $11 |
| Metformin | 57 | $411 | $7 |
| Escitalopram | 40 | $401 | $10 |
| Clopidogrel | 18 | $373 | $21 |
| Carvedilol | 34 | $358 | $11 |
| Pravastatin | 30 | $356 | $12 |
| Bupropion | 14 | $343 | $24 |
| Hydrochlorothiazide | 66 | $332 | $5 |
| Sertraline | 59 | $321 | $5 |
| Citalopram Hbr | 23 | $263 | $11 |
| Mirtazapine | 13 | $242 | $19 |
| Paroxetine | 11 | $232 | $21 |
| Allopurinol | 24 | $227 | $9 |
| Lisinopril | 65 | $215 | $3 |
| Hydrocodone-Acetaminophen | 13 | $199 | $15 |
| Trazodone | 29 | $183 | $6 |
| Clonazepam | 49 | $173 | $4 |
| Cyclobenzaprine | 18 | $152 | $8 |
| Dicyclomine | 14 | $147 | $11 |
| Tamsulosin | 15 | $147 | $10 |
| Simvastatin | 28 | $139 | $5 |
| Metformin Hcl Er | 42 | $116 | $3 |
| Atenolol | 20 | $110 | $5 |
| Metoprolol | 13 | $109 | $8 |
| Glimepiride | 14 | $105 | $7 |
| Fluoxetine | 19 | $103 | $5 |
| Alprazolam | 15 | $102 | $7 |
| Meloxicam | 22 | $102 | $5 |
| Furosemide | 27 | $91 | $3 |
| Chlorthalidone | 12 | $90 | $8 |
| Glipizide | 14 | $83 | $6 |
| Buspirone | 12 | $74 | $6 |
| Tizanidine | 14 | $70 | $5 |
| Tramadol | 15 | $64 | $4 |
| Ciprofloxacin | 12 | $64 | $5 |
| Triamcinolone Acetonide | 12 | $59 | $5 |
2020: 51 drugs
| Jardiance | 16 | $22,918 | $1,432 |
| Eliquis | 15 | $7,551 | $503 |
| Humulin N | 13 | $4,134 | $318 |
| Atorvastatin | 115 | $1,329 | $12 |
| Levothyroxine | 54 | $1,277 | $24 |
| Proair Hfa | 15 | $1,086 | $72 |
| Synthroid | 12 | $1,052 | $88 |
| Metoprolol | 40 | $907 | $23 |
| Ezetimibe | 15 | $890 | $59 |
| Potassium Chloride | 36 | $767 | $21 |
| Gabapentin | 46 | $664 | $14 |
| Albuterol Sulfate Hfa | 16 | $644 | $40 |
| Quetiapine | 28 | $573 | $20 |
| Losartan | 51 | $545 | $11 |
| Omeprazole | 25 | $501 | $20 |
| Rosuvastatin | 27 | $496 | $18 |
| Amitriptyline | 17 | $465 | $27 |
| Amlodipine Besylate | 64 | $454 | $7 |
| Chlorthalidone | 12 | $443 | $37 |
| Montelukast | 26 | $418 | $16 |
| Escitalopram | 20 | $353 | $18 |
| Hydrochlorothiazide | 50 | $344 | $7 |
| Alendronate | 29 | $332 | $11 |
| Sertraline | 21 | $319 | $15 |
| Fluticasone Propionate | 15 | $317 | $21 |
| Cefdinir | 12 | $312 | $26 |
| Baclofen | 12 | $294 | $24 |
| Clonazepam | 35 | $290 | $8 |
| Pantoprazole | 38 | $279 | $7 |
| Lisinopril | 46 | $250 | $5 |
| Buspirone | 12 | $229 | $19 |
| Metformin | 19 | $220 | $12 |
| Trazodone | 30 | $217 | $7 |
| Diclofenac | 13 | $210 | $16 |
| Citalopram Hbr | 19 | $203 | $11 |
| Pravastatin | 11 | $190 | $17 |
| Spironolactone | 13 | $186 | $14 |
| Tramadol | 22 | $172 | $8 |
| Cyclobenzaprine | 11 | $158 | $14 |
| Glimepiride | 12 | $149 | $12 |
| Carvedilol | 20 | $147 | $7 |
| Allopurinol | 12 | $136 | $11 |
| Furosemide | 27 | $127 | $5 |
| Simvastatin | 15 | $115 | $8 |
| Zolpidem | 20 | $114 | $6 |
| Paroxetine | 11 | $111 | $10 |
| Hydrocodone-Acetaminophen | 11 | $105 | $10 |
| Atenolol | 12 | $97 | $8 |
| Metformin Hcl Er | 16 | $86 | $5 |
| Acetaminophen-Codeine | 11 | $72 | $7 |
| Lorazepam | 11 | $46 | $4 |
2019: 19 drugs
| Atorvastatin | 85 | $1,295 | $15 |
| Metoprolol | 20 | $719 | $36 |
| Amitriptyline | 23 | $515 | $22 |
| Levothyroxine | 17 | $510 | $30 |
| Amlodipine Besylate | 46 | $481 | $10 |
| Clonazepam | 37 | $473 | $13 |
| Allopurinol | 13 | $297 | $23 |
| Montelukast | 19 | $272 | $14 |
| Losartan | 31 | $268 | $9 |
| Lisinopril | 40 | $250 | $6 |
| Quetiapine | 18 | $177 | $10 |
| Pantoprazole | 15 | $171 | $11 |
| Metformin | 18 | $162 | $9 |
| Hydrochlorothiazide | 36 | $136 | $4 |
| Cyclobenzaprine | 15 | $130 | $9 |
| Gabapentin | 16 | $113 | $7 |
| Simvastatin | 12 | $86 | $7 |
| Hydrocodone-Acetaminophen | 11 | $58 | $5 |
| Tramadol | 12 | $27 | $2 |
2018: 4 drugs
| Atorvastatin | 23 | $291 | $13 |
| Hydrocodone-Acetaminophen | 11 | $111 | $10 |
| Hydrochlorothiazide | 12 | $75 | $6 |
| Amlodipine Besylate | 12 | $57 | $5 |
2017: 12 drugs
| Atorvastatin | 49 | $1,257 | $26 |
| Levothyroxine | 30 | $661 | $22 |
| Metoprolol | 13 | $408 | $31 |
| Gabapentin | 36 | $366 | $10 |
| Fluticasone Propionate | 17 | $291 | $17 |
| Pantoprazole | 21 | $274 | $13 |
| Amlodipine Besylate | 36 | $269 | $7 |
| Lisinopril | 28 | $164 | $6 |
| Simvastatin | 11 | $116 | $11 |
| Metformin | 13 | $107 | $8 |
| Sertraline | 12 | $78 | $7 |
| Lisinopril-Hydrochlorothiazide | 11 | $50 | $5 |
2016: 19 drugs
| Atorvastatin | 41 | $1,276 | $31 |
| Levothyroxine | 25 | $615 | $25 |
| Losartan | 22 | $555 | $25 |
| Pravastatin | 12 | $528 | $44 |
| Fluticasone Propionate | 28 | $416 | $15 |
| Amlodipine Besylate | 41 | $339 | $8 |
| Gabapentin | 18 | $243 | $13 |
| Pantoprazole | 16 | $190 | $12 |
| Lisinopril | 32 | $187 | $6 |
| Fluoxetine | 19 | $184 | $10 |
| Sertraline | 18 | $148 | $8 |
| Metformin | 15 | $147 | $10 |
| Trazodone | 19 | $97 | $5 |
| Glipizide | 12 | $85 | $7 |
| Hydrochlorothiazide | 14 | $76 | $5 |
| Furosemide | 17 | $64 | $4 |
| Carvedilol | 11 | $56 | $5 |
| Metoprolol | 12 | $43 | $4 |
| Meloxicam | 11 | $39 | $4 |
2015: 6 drugs
| Metoprolol | 17 | $635 | $37 |
| Levothyroxine | 21 | $369 | $18 |
| Atorvastatin | 11 | $295 | $27 |
| Pantoprazole | 13 | $216 | $17 |
| Amlodipine Besylate | 19 | $167 | $9 |
| Furosemide | 12 | $49 | $4 |
Money from drug and device companies
$99 in 2025
| 2025 | 2 | 5 | None | $99 |
| 2024 | 3 | 12 | None | $221 |
| 2023 | 3 | 14 | None | $289 |
| 2022 | 2 | 2 | None | $41 |
| 2021 | 2 | 2 | None | $30 |
| 2019 | 3 | 5 | None | $74 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
See all 5 published payments
| Abbvie | Meals · 2025-11-13 | Qulipta | $25 |
| Pfizer | Meals · 2025-10-30 | Prevnar 20 | $17 |
| Abbvie | Meals · 2025-08-01 | Qulipta | $26 |
| Abbvie | Meals · 2025-06-06 | Qulipta | $14 |
| Abbvie | Meals · 2025-01-31 | Qulipta | $17 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $221
| Abbvie | Qulipta | $184 | 10 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $19 | 1 payment
|
| Lilly USA | Jardiance | $18 | 1 payment
|
2023: $289
| AbbVie | Ubrelvy | $200 | 9 payments
|
| Lilly USA | Mounjaro | $70 | 4 payments
|
| Pfizer | Prevnar 20 | $19 | 1 payment
|
2022: $41
| Mayne Pharma | None | $22 | 1 payment
|
| Lilly USA | Mounjaro | $20 | 1 payment
|
2021: $30
| Biohaven Pharmaceuticals | Nurtec Odt | $19 | 1 payment
|
| AbbVie | Ubrelvy | $12 | 1 payment
|
2019: $74
| Teva Pharmaceuticals USA | Ajovy | $43 | 3 payments
|
| Merck Sharp & Dohme | Nexplanon | $16 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kyleena | $15 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Merck Sharp & Dohme LLC · A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate the Efficacy and Safety of Mk-4482 for the Prevention of Covid-19 Laboratory-Confirmed Sars-Cov-2 Infection With Symptoms in Adults Residing With A Person With Covid-19 · 2024 | Their institution | $2,500 |
| Merck Sharp & Dohme LLC · A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate the Efficacy and Safety of Mk-4482 for the Prevention of Covid-19 Laboratory-Confirmed Sars-Cov-2 Infection With Symptoms in Adults Residing With A Person With Covid-19 · 2023 | Their institution | $604 |
Professional record
- NPI
- 1588076608
- Licence
- LA 306973
- Trained
- Tulane University School of Medicine, 2014
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- LA 2368117
- Taxonomy
- Family medicine (207Q00000X); Student in a training program (390200000X)
- Mailing address
- 3600 Prytania St Ste 35, New Orleans, LA, 70115
- NPI first listed
- 2014-05-22
- NPI last updated
- 2019-03-06
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 4228 Houma Blvd, Metairie, LA, 70006